Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine versus sufentanil for non-intubated general anesthesia during ERCP
ChiCTR1900020972Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Condition requiring endoscopic retrograde cholangiopancreatography comparing Nalbuphine group with Sufentanil group (2 arms). Primary endpoints: Blood pressure, Heart rate and 4 more. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
nalbuphinesufentanil
03
Conditions
Condition requiring endoscopic retrograde cholangiopancreatography
Beyond the preview
Go deeper on ChiCTR1900020972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020972.